Evidence map›Paper›PMID 26035325›Full record

ArticleAIDS (London, England)2015

Soluble CD14 is a nonspecific marker of monocyte activation.

Carey L Shive, Wei Jiang, Donald D Anthony, Michael M Lederman

Abstract read
In one paragraph

Article in AIDS (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 152 papers.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 235 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Impaired Responses to In Vitro Lipopolysaccharide-Induced Stimulation After Long-Term, Rotating Shift Work.International journal of environmental research and public health · 2025
    Article
  19. Article
  20. Review

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Carey L ShiveaCenter for AIDS Research, Case Western Reserve University School of Medicine, Cleveland, Ohio bDepartment of Microbiology and Immunology, Division of Infectious Diseases, Medical University of South Carolina, Charleston, South Carolina cVeterans Administration Medical Center, Cleveland, Ohio, USA.
Wei Jiang
Donald D Anthony
Michael M Lederman
Case Western Reserve University · USMedical University of South Carolina · USUnited States Department of Veterans Affairs · USUniversity School · US

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
AIDS Clinical Trials Group NetworkU01AI068636 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI KURITZKES, DANIEL R. · 2006 to 2010
$147.1M
WG3: HIV, Co-infections and Co-morbiditiesP30AI036219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI Sharon L. Hillier, JONATHAN KARN · 1994 to 2026
$50.0M
Case Clinical Trials Unit: Administrative Supplement NOSI AI-20-031.UM1AI069501 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI George Yendewa · 2012 to 2026
$40.4M
Specimen Acquisition and Distribution CoreP01AI076174 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI LANDAY, ALAN L · 2008 to 2012
$10.9M
Effects of IL-6 blockade in treated HIV infectionU01AI105937 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI LEDERMAN, MICHAEL MARCEL, RODRIGUEZ, BENIGNO · 2013 to 2017
$5.8M
Synergistic effect of HIV virions and bacterial LPS on memory B cell apoptosisR01AI091526 · NIAID · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI JIANG, WEI · 2011 to 2015
$1.4M
Role of ENPP2, immune activation and age on neoantigen response during HCVI01CX001104 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI ANTHONY, DONALD D · 2015 to 2018
–
CSRD VA I01 CX001104NIAID NIH HHS AI 076174NIAID NIH HHS AI091526NIAID NIH HHS AI 105937NIAID NIH HHS AI 36219NIAID NIH HHS AI 68636NIAID NIH HHS P01 AI076174NIAID NIH HHS P30 AI036219NIAID NIH HHS R01 AI091526NIAID NIH HHS U01 AI068636NIAID NIH HHS U01 AI105937NIAID NIH HHS UM1 AI068636NIAID NIH HHS UM1 AI069501
6 · The paper itself

Abstract

Soluble CD14 is associated with morbidity and mortality in HIV disease. It is a co-receptor for lipopolysaccharide (LPS) that is released from monocytes upon activation. We demonstrate here, that inflammatory cytokines can induce the release of sCD14 in peripheral blood mononuclear cell cultures from healthy donors, and that TLR ligands other than LPS can cause a decrease in the monocyte cell surface expression of CD14. Thus, sCD14 is a marker of monocyte activation, not restricted to activation by LPS.

Indexed as

BiomarkersCells, CulturedCytokinesHumansLipopolysaccharide ReceptorsMonocytesBiomarkersCytokinesLipopolysaccharide Receptors

Identifiers

PMID26035325
PMCPMC4452959
OpenAlexW2190014693

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.